Samraat S.  Raha net worth and biography

Samraat Raha Biography and Net Worth

Sam is the president of Agilent's Diagnostics and Genomics Group. He is responsible for overall strategy, along with business and financial results, for the group which includes the pathology, genomics, companion diagnostics, and Nucleic Acid Solutions (therapeutic oligonucleotides) businesses.

Sam returned to Agilent in early 2017 to lead the Strategy and Corporate Development function. He led the creation of Agilent's first long range strategy while strengthening Agilent's M&A capabilities, overseeing numerous acquisitions that strategically enhanced Agilent's offerings to customers.

Prior to re-joining Agilent, Sam was vice president of global marketing at Illumina, a San Diego-based life sciences company. He was responsible for leading the overall marketing function for Illumina including product management, clinical marketing, and corporate marketing. He was an integral part of defining a multi-year sequencing platform road-map and successfully launched several sequencing systems and consumables to drive market defining growth.

Prior to his years at Illumina, Sam was vice president and general manager of the genomic assays business unit at Life Technologies, with P&L responsibility for the TaqMan™ franchise and next generation qPCR instruments and solutions.

Earlier in his Agilent career, Sam was vice president and general manager of the Americas with responsibility for sales, regional marketing, and customer and applications support for the Life Sciences and Chemical Analysis Group.

Sam earned his MBA from Santa Clara University and has an undergraduate degree in molecular and cell biology from the University of California, Berkeley.

How do I contact Samraat S. Raha?

The corporate mailing address for Mr. Raha and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at [email protected]. Learn More on Samraat S. Raha's contact information.

Has Samraat S. Raha been buying or selling shares of Agilent Technologies?

Samraat S. Raha has not been actively trading shares of Agilent Technologies during the last quarter. Most recently, Samraat S. Raha sold 1,000 shares of the business's stock in a transaction on Wednesday, March 31st. The shares were sold at an average price of $127.50, for a transaction totalling $127,500.00. Learn More on Samraat S. Raha's trading history.

Who are Agilent Technologies' active insiders?

Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Philip Binns (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (Chairman of the Board & CEO), Michael Mcmullen (CEO), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.

Are insiders buying or selling shares of Agilent Technologies?

In the last twelve months, insiders at the medical research company sold shares 11 times. They sold a total of 95,401 shares worth more than $13,890,269.70. The most recent insider tranaction occured on September, 27th when CEO Padraig Mcdonnell sold 47 shares worth more than $7,050.00. Insiders at Agilent Technologies own 0.3% of the company. Learn More about insider trades at Agilent Technologies.

Information on this page was last updated on 9/27/2024.

Samraat S. Raha Insider Trading History at Agilent Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/31/2021Sell1,000$127.50$127,500.00
See Full Table

Samraat S. Raha Buying and Selling Activity at Agilent Technologies

This chart shows Samraat S Raha's buying and selling at Agilent Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Agilent Technologies Company Overview

Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $134.51
Low: $133.23
High: $135.53

50 Day Range

MA: $135.85
Low: $125.70
High: $144.58

2 Week Range

Now: $134.51
Low: $124.16
High: $155.35

Volume

4,342,841 shs

Average Volume

1,736,894 shs

Market Capitalization

$38.65 billion

P/E Ratio

30.43

Dividend Yield

0.71%

Beta

1.07